Infineon Technologies, a global semiconductor leader in power systems and IoT, has acquired the Zurich-based startup 3db Access, a pioneer in secured low power Ultra-Wideband (UWB) technology and already today a preferred IP provider for
Tags :Manuel Bigler
The Federal Supreme Court confirms far-reaching injunctions granted in favor of the German science and technology company Merck by the Commercial Court of the Canton of Zurich against Merck’s US competitor MSD. Based in
ITS Kanal Services acquired Restclean, a specialist in the field of WC cleaning and renovation. The Swiss ITS Kanal Services is a full-service provider for the maintenance and value preservation of sewer systems and surfaces.
Walder Wyss advises Swiss biotech Alentis Therapeutics in connection with their USD 105m Series C funding to support the development of its lead assets. The funding round was led by Jeito Capital together with Novo
Intel 471, a globally provider of cyber threat intelligence for leading intelligence, security and fraud, acquired SpiderFoot, a best-in-class provider of open-source intelligence, attack surface management and digital investigations. The terms of the deal were not
Cembra Money Bank, a renowed Swiss provider of financing solutions and services, has announced that it has agreed to acquire a 100% stake in Byjuno and its sister company, Intrum Finance Services, from Intrum for a
Walder Wyss announced the appointment of Simone Wetzstein and Martin Zobl (both pictured above) as partners in the firm, effective from 1st of January, 2022. Simone Wetzstein is a partner in the Employment Law Team. She
Walder Wyss acted as legal counsel to Alentis Therapeutics on the USD 67 million series B financing round. Morningside Venture Investments led the financing, joined by Jeito Capital and Series A investors Biomed Partners, BB Pureos
Walder Wyss’ IP team successfully represented the pharmaceutical company Merck in appeal proceedings before the Swiss Federal Supreme Court against its US competitor MSD. The case Following World War I, Merck’s US subsidiary, which
The team was led by partner Stefan Knobloch (Corporate/M&A - pictured) and managing associate Fabienne Anner (Corporate/M&A)
